U.S. Biotech Stock News

Global Ship Lease (GSL) has quietly turned into one of the stronger performers in shipping, with the stock climbing over the past year even as revenue and net income have both slipped. See our latest analysis for Global Ship Lease. That steady climb in the share price, now at $34.53, reflects investors warming to Global Ship Lease again, with a strong year to date share price return of 52.18 percent and a powerful 68.78 percent one year total shareholder return suggesting momentum is still...

Fresh analyst projections pointing to higher revenue have put Construction Partners (ROAD) back on investors radar, pairing upbeat expectations with a strong history of earnings growth and steadily improving free cash flow margins. See our latest analysis for Construction Partners. The share price has climbed to around $112, with a robust year to date share price return of roughly 28% and a standout three year total shareholder return above 300%, signaling momentum that investors clearly...

If you are wondering whether Amentum Holdings is still a smart place to put fresh money to work, you are not alone, and this article is going to tackle that value question head on. The stock has climbed 4.3% over the last week, 17.9% over the past month, and is now up 38.1% year to date, with a striking 51.0% gain over the last year, which naturally raises the question of whether the market is getting ahead of itself or just starting to catch up. Recent headlines have focused on Amentum...

If you are wondering whether BioMarin Pharmaceutical is a bargain or a value trap at around $60 a share, you are not alone, and this piece will walk through what the numbers actually say. After a long slide that has left the stock down about 9.7% over the past year and around 40.9% over three years, the recent 16.1% jump in the last week and 8.4% rise over the past month suggest sentiment might finally be turning. Much of this renewed interest has been driven by pipeline and regulatory...

Setting the scene for Tootsie Roll Industries stock Tootsie Roll Industries (TR) has quietly outperformed many consumer staples this year, and that steady climb makes its recent pullback an interesting spot for investors rethinking defensive names in a choppy market. See our latest analysis for Tootsie Roll Industries. With the share price now around $37.42, Tootsie Roll’s year to date share price return of 18.19 percent and five year total shareholder return of 54.06 percent suggest steady,...

Wondering if Travelers Companies is still attractively priced after its big run, or if the easy money has already been made? This breakdown will help you assess whether the current price still stacks up against its fundamentals. The stock has climbed to around $293.84, delivering 0.9% over the last week, 1.0% over the past month, and 22.0% year to date, with gains of 23.0% over 1 year, 65.3% over 3 years, and 133.6% over 5 years. Recent coverage has highlighted Travelers positioning in the...

CBRE Group (CBRE) just reshuffled its senior leadership across Real Estate Investments, Advisory Services, and Trammell Crow Company, a move clearly designed to tighten execution and support its next phase of global growth. See our latest analysis for CBRE Group. Those leadership promotions land against a backdrop of solid momentum, with the share price returning nearly 27 percent year to date and a strong three year total shareholder return signaling investor confidence in CBRE’s long term...

If you are wondering whether Northrop Grumman is still attractive after its recent rally or whether it might be better to wait for a different entry point, this breakdown is for you. The stock has quietly delivered solid returns, rising 3.2% over the last week, 3.0% over the past month, and 24.4% year to date, while gaining 25.8% over 1 year and 109.0% over 5 years. These moves come as defense spending tailwinds continue to support contractors across the sector, including Northrop Grumman...

SoFi Technologies (SOFI) just shook up its fintech playbook by launching SoFiUSD, a fully reserved dollar stablecoin, and relaunching crypto trading inside its FDIC insured banking app, moves that could reshape its long term revenue mix. See our latest analysis for SoFi Technologies. Those moves are landing in a stock that has already re-rated hard, with a year to date share price return of 94.48% and a three year total shareholder return above 500%. Momentum is still firmly on SoFi's side...

In recent weeks, Deckers Outdoor has drawn heightened investor attention as it consistently exceeded consensus EPS and revenue estimates across the last four quarters, earning a favorable Zacks Rank #2 rating. At the same time, BTIG commentary pointing to both category strength in fashion boots and mixed conditions for Deckers underscores how brand mix and execution are becoming more important than broad footwear trends. We’ll now examine how Deckers’ consistent earnings outperformance and...

Earlier this week, Baker Hughes announced it received a Full Notice To Proceed from Technip Energies, on behalf of Commonwealth LNG, to supply six LM9000-powered refrigerant turbo compressors for a 9.5 million tonnes per annum export facility under development in Cameron, Louisiana. This LNG equipment award, alongside Baker Hughes’ recent multi-year artificial lift and digital optimization contract with Kuwait Oil Company, underscores how its gas technology and production solutions are being...

Ameren (AEE) has quietly outperformed many defensive utilities this year, even after a recent pullback. With shares up roughly 13% over the past year, investors are weighing how much upside remains. See our latest analysis for Ameren. The recent pullback, including a roughly 4.7% 1 month share price return, has come after a strong run, with the year to date share price return over 12% and a 1 year total shareholder return above 13%. This suggests momentum is cooling rather than collapsing. If...

Savara (SVRA) just took a key regulatory step by resubmitting its Biologics License Application for MOLBREEVI and asking the FDA for Priority Review, a move that could accelerate its path in autoimmune PAP. See our latest analysis for Savara. Investors have been steadily repricing Savara as MOLBREEVI advances, with the latest share price at $6.40 and a strong 30 day share price return of 22.84 percent building on an 84.44 percent 90 day share price return and a 100 percent one year total...

CAVA Group (CAVA) has quietly climbed over the past week, even though the stock is still down sharply this year. That disconnect naturally raises a key question for investors: what has really changed? See our latest analysis for CAVA Group. The recent 1 month share price return of 31.88 percent at a last close of 61.72 dollars caps a sharp near term rebound. However, it sits against a much weaker backdrop, with the year to date share price return at negative 46.41 percent and 1 year total...

Commercial momentum puts Rezolve AI in focus Rezolve AI (RZLV) is getting extra attention after showcasing new global deployments with brands like GAP and Banana Republic, plus enterprise renewals and upsells that point to strengthening, recurring demand for its platform. See our latest analysis for Rezolve AI. Those new deployments and bullish guidance have helped the stock stage a sharp near term rebound, with a 7 day share price return of 21.25 percent, even though longer term total...

LTC Properties, Inc. recently completed two Senior Housing Operating Portfolio acquisitions in Tennessee and Wisconsin and redeemed US$6.4 million of preferred equity, while also fulfilling its US$460 million 2025 investment guidance focused largely on SHOP assets. The move, alongside plans for a further US$110 million of SHOP acquisitions in early 2026, underscores LTC’s emphasis on scaling senior housing operations and recycling capital into higher-yielding structures. We’ll now examine...

Recent commentary around Avis Budget Group (CAR) is focusing on a tougher backdrop, including flat rental days, softer returns on capital, and rising odds of a potentially dilutive capital raise. See our latest analysis for Avis Budget Group. That backdrop helps explain why, despite a robust year to date share price return of 63.87 percent and a five year total shareholder return of 269.09 percent, the more recent 90 day share price return of negative 19.27 percent suggests momentum is fading...

Surf Air Mobility recently reported Q3 2025 results that exceeded its own revenue guidance, raised its full-year outlook, maintained profitability expectations for airline operations, and expanded its SurfOS software platform through a new partnership with Palantir in the regional air mobility segment. Following these developments, Zacks upgraded Surf Air Mobility to a Rank #2, reflecting higher earnings estimates and a more positive earnings outlook tied to both its core airline business...

Wondering if Vita Coco Company at around $53 a share is still a refreshing opportunity or if most of the upside has already been squeezed out? You are not alone, and that is exactly what we are going to unpack here. The stock has climbed about 4.3% over the last week and 4.4% over the past month, while racking up a 52% gain year to date and 48.5% over the past year, with a 293.9% return over three years that has put it on growth investors radar. Behind these moves is a narrative around Vita...

Honeywell International (HON) has quietly bounced about 4% over the past month even as its year to date performance remains negative. This setup has some long term investors revisiting the stock’s risk reward. See our latest analysis for Honeywell International. The recent 1 month share price return of 4.38 percent, against a negative year to date share price return of 12.68 percent and modest 3 year total shareholder return, suggests sentiment is stabilising as investors reassess Honeywell’s...

If you have been wondering whether Hamilton Lane is still a smart buy after its big run in alternative assets, you are not alone. This article is going to dig into what the current share price really implies about future returns. The stock has bounced recently, rising about 5.2% over the last week and 15.3% over the past month. It is still down around 7.0% year to date and roughly 6.5% over the last 12 months, which hints at shifting sentiment rather than a straight line growth...

If you are wondering whether Ecolab’s current share price really reflects its quality and growth story, you are not alone. This article is designed to unpack exactly that question in plain English. The stock now trades around $265.58, up 1.4% over the last week but slightly down 1.2% over the past month, while still sitting on a gain of 15.0% year to date and 90.7% over three years. Those moves come as investors focus on Ecolab’s role in long term themes such as water scarcity, industrial...

If you have been wondering whether Church & Dwight is quietly becoming a bargain or just a consumer staples comfort stock, you are in the right place to dig into what the market might be missing. Despite its reputation as a steady household products name, the share price has slipped to around $85.46, with a 3.3% gain over the last 30 days but a much steeper drop of 17.7% year to date and 18.7% over the past year, hinting at shifting sentiment around its growth prospects and risk...

If you are wondering whether Teva Pharmaceutical Industries is still good value after its big comeback, you are not alone. This stock has quietly shifted from a turnaround story to a serious contender on many investors' watchlists. Teva shares now trade around 31.74, after climbing 5.6% over the last week, 28.1% over the past month, 49.0% year to date and 41.6% over the last year, with a 245.8% gain over three years and 230.6% over five years reshaping how the market views its...